Amikacin

Welcome to Dwaey, specifically on Amikacin page.
This medicine contains important and useful components, as it consists of
Amikacin is available in the market in concentration.

Generic Name of Amikacin - Learn More

Amikacin

Amikacin Precaution - What You Need to Know

Amikacin is an aminoglycoside antibiotic with specific precautions for use in certain populations and conditions. Pregnant women should use Amikacin only if the potential benefit justifies the risk to the fetus, as it is classified as a Category D drug by the FDA. Aminoglycosides have been associated with fetal harm, including ototoxicity and nephrotoxicity. It is also present in breast milk, so caution should be exercised in breastfeeding women, as it may affect the nursing infant's kidney function or hearing. Patients with pre-existing kidney conditions, such as renal impairment or those undergoing hemodialysis, are at increased risk of nephrotoxicity and should be monitored closely for signs of kidney dysfunction.

Monitoring parameters include serum creatinine levels, urine output, and hearing function during therapy. Therapeutic drug monitoring (TDM) is crucial for determining appropriate serum drug concentrations, particularly in patients with renal impairment, to avoid toxicity. In terms of misuse, Amikacin has no significant potential for abuse or dependency; however, improper use can contribute to the development of resistance, making it less effective in the future.

Amikacin Indication - Uses and Benefits

Amikacin is primarily indicated for the treatment of serious bacterial infections caused by susceptible Gram-negative organisms, including infections of the urinary tract, respiratory tract, bone, skin, and soft tissues, as well as sepsis. It is particularly used when other antibiotics have failed due to its potency against multi-drug-resistant strains. It is also used in combination therapy to treat tuberculosis, particularly in drug-resistant cases.

The drug is often considered for empiric therapy in severe infections, with specific use guided by local susceptibility patterns. For cystic fibrosis patients, it may be used to treat chronic Pseudomonas aeruginosa infections. Off-label, Amikacin has been employed in cases of endocarditis, as well as certain central nervous system infections, when other antibiotics are ineffective. Clinical guidelines suggest using Amikacin cautiously in settings where local resistance rates are high, and its efficacy should be monitored using TDM.

Amikacin Contraindications - Important Warnings

Amikacin is contraindicated in patients with known hypersensitivity to aminoglycosides or any component of the formulation. It is also contraindicated in patients with a history of previous serious aminoglycoside-induced toxicity, particularly those with prior episodes of nephrotoxicity or ototoxicity. Those with myasthenia gravis or other neuromuscular disorders should avoid Amikacin, as aminoglycosides can exacerbate muscle weakness by impairing neuromuscular transmission.

The drug should not be used in individuals with severe renal impairment or end-stage renal disease (ESRD) without careful dose adjustments, as there is a heightened risk of nephrotoxicity. Age restrictions include caution in neonates and infants due to immature renal function, which may increase the risk of toxic accumulation. Additionally, patients who are dehydrated or have a history of dehydration should use Amikacin cautiously, as it may exacerbate renal problems. Pregnant women should avoid Amikacin unless no safer alternatives are available, given its potential for fetal harm.

Amikacin Side Effects - What to Expect

Common side effects of Amikacin include nausea, vomiting, diarrhea, and headache. These are typically mild and often resolve as the body adjusts to the drug. Serious side effects, however, may occur, including nephrotoxicity, ototoxicity, and neurotoxicity. Nephrotoxicity is characterized by increased serum creatinine, reduced urine output, and signs of acute kidney injury, while ototoxicity manifests as tinnitus or hearing loss, which can be irreversible if not detected early.

Long-term use or high doses of Amikacin increase the likelihood of these severe side effects, particularly in patients with pre-existing renal impairment. Aminoglycosides can also cause vestibular toxicity, leading to dizziness or balance issues. In rare cases, Amikacin can lead to allergic reactions such as rash, fever, or difficulty breathing.

To mitigate these effects, it is important to perform regular renal and auditory function assessments, and to adjust the dosing schedule based on renal function. Patients should immediately report any signs of hearing changes, balance issues, or decreased urine output to their healthcare provider.

Amikacin Pregnancy Category ID - Safety Information

4

Amikacin Mode of Action - How It Works

Amikacin exerts its therapeutic effects by binding to the 30S subunit of bacterial ribosomes, thereby inhibiting protein synthesis. This results in the production of abnormal, dysfunctional proteins and ultimately leads to bacterial cell death. Amikacin's broad-spectrum activity against Gram-negative bacteria, including multi-drug resistant strains, makes it a critical option in the treatment of serious infections.

Pharmacokinetically, Amikacin is absorbed poorly from the gastrointestinal tract and is usually administered intravenously or intramuscularly. Once in circulation, it has a relatively short half-life and is primarily eliminated unchanged via the kidneys. This makes renal function a critical determinant of its pharmacokinetics. Unlike many antibiotics, which rely on the disruption of cell walls, Amikacin’s mechanism of action focuses on inhibiting bacterial protein synthesis, which is crucial for its ability to treat resistant infections.

Its selective binding to the bacterial ribosome ensures that it does not affect human cells, although its potential to cause nephrotoxicity and ototoxicity highlights the importance of precise dosing.

Amikacin Drug Interactions - What to Avoid

Amikacin has several significant drug-drug interactions that may either increase the risk of adverse effects or reduce its therapeutic efficacy. Co-administration with other nephrotoxic drugs (e.g., vancomycin, cisplatin) or ototoxic medications (e.g., furosemide) can increase the risk of renal damage or hearing loss. Therefore, monitoring of renal function and hearing is essential when these drugs are used together.

Amikacin may also interact with neuromuscular blocking agents (e.g., pancuronium, vecuronium), leading to prolonged paralysis, which is of particular concern during surgery. For this reason, anesthesiologists should be aware of Amikacin therapy in patients undergoing procedures requiring neuromuscular blockade. There are no known major food or alcohol interactions, but excessive alcohol consumption should be avoided as it may exacerbate potential side effects such as dizziness or ototoxicity.

To manage these interactions, clinicians should carefully monitor serum drug levels of Amikacin, particularly when combining it with other renal or ototoxic drugs, and adjust the dosage accordingly.

Amikacin Adult Dose - Recommended Dosage

The standard adult dose of Amikacin for serious infections is typically 15 mg/kg body weight per day, divided into two or three doses, depending on the severity of the infection and renal function. For uncomplicated infections, a single daily dose may suffice, while more complex or resistant infections require multiple daily doses. It is essential to adjust the dose based on the patient's renal function, as reduced kidney clearance increases the risk of toxicity.

Amikacin is usually administered via intravenous infusion or intramuscular injection. For serious infections such as sepsis or respiratory infections, higher doses (up to 30 mg/kg/day) may be recommended. The maximum recommended dose for an adult patient is typically 1.5 g/day. Adjustments may be required for those with impaired renal function to avoid accumulation and toxicity. Therapeutic drug monitoring (TDM) is often employed to ensure serum concentrations remain within a safe range, typically 20-30 µg/mL.

Amikacin Child Dose - Dosage for Children

Pediatric dosing of Amikacin varies by age, weight, and clinical condition. The typical dose for infants and children is 15-20 mg/kg/day, divided into two to three doses. For severe infections, particularly in neonates, the dosage may be adjusted upward to 20-30 mg/kg/day.

Neonates require special consideration due to their immature renal function, and dose adjustments should be made based on gestational age and postnatal age. Close monitoring of renal function, hearing, and overall growth is essential during therapy to prevent potential toxic effects. Pediatric patients may also require more frequent monitoring due to their developing organs and systems, which may impact drug metabolism and excretion. Regular therapeutic drug monitoring (TDM) is particularly important for children receiving high doses or prolonged therapy.

Amikacin Renal Dose - Dosage for Kidney Conditions

For patients with renal impairment, the dosage of Amikacin must be adjusted based on the degree of renal dysfunction. In patients with creatinine clearance (CrCl) greater than 60 mL/min, no dose adjustment is typically required, although careful monitoring is recommended. In those with mild renal impairment (CrCl 30-60 mL/min), the dose may be reduced by 25-50%, and for moderate to severe impairment (CrCl < 30 mL/min), a further reduction or extended dosing intervals may be necessary.

For patients undergoing hemodialysis, Amikacin should be administered after dialysis to account for significant drug removal during the procedure. Close monitoring of renal function and serum drug levels is crucial to prevent toxic accumulation, especially in patients with fluctuating kidney function.